Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTROPIC phase III photodynamic diagnosis study with SPP-005 in ovarian, fallopian tube, or peritoneal cancer
jRCT2021250012Phase 3Active, not recruiting
- Sponsor
- SBI Pharmaceuticals
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of 5-aminolevulinic acid in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC), sponsored by SBI Pharmaceuticals. Primary endpoint: Sensitivity of biopsy tissue specimens under blue and white illumination. Started Nov 2025; status: active, not recruiting.
02
Drugs
5-aminolevulinic acid
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on jRCT2021250012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2021250012.